Page last updated: 2024-10-25

clonidine and Bone Loss, Perimenopausal

clonidine has been researched along with Bone Loss, Perimenopausal in 1 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eden, J1

Reviews

1 review available for clonidine and Bone Loss, Perimenopausal

ArticleYear
ENDOCRINE DILEMMA: Managing menopausal symptoms after breast cancer.
    European journal of endocrinology, 2016, Volume: 174, Issue:3

    Topics: Administration, Intravaginal; Administration, Topical; Atrophy; Bone Density Conservation Agents; Br

2016